These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 15634446)
21. Regulation of TRAIL receptor expression by β-catenin in colorectal tumours. Jalving M; Heijink DM; Koornstra JJ; Boersma-van Ek W; Zwart N; Wesseling J; Sluiter WJ; de Vries EG; Kleibeuker JH; de Jong S Carcinogenesis; 2014 May; 35(5):1092-9. PubMed ID: 24379239 [TBL] [Abstract][Full Text] [Related]
22. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions. Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038 [TBL] [Abstract][Full Text] [Related]
23. β-catenin helices in the cytoplasm of sessile serrated adenoma/polyps and conventional colorectal adenomas. Rubio CA; Kaufeldt A; Koha R; Ushoida M; Lindahl J; Kis LL Anticancer Res; 2015 Feb; 35(2):929-34. PubMed ID: 25667476 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of nuclear β-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis. Wang L; Cheng H; Liu Y; Wang L; Yu W; Zhang G; Chen B; Yu Z; Hu S Ann Surg Oncol; 2011 Jun; 18(6):1553-9. PubMed ID: 21207157 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048 [TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031 [TBL] [Abstract][Full Text] [Related]
27. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285 [TBL] [Abstract][Full Text] [Related]
28. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. Hlubek F; Spaderna S; Jung A; Kirchner T; Brabletz T Int J Cancer; 2004 Jan; 108(2):321-6. PubMed ID: 14639622 [TBL] [Abstract][Full Text] [Related]
29. Identification of marker genes and pathways specific to precancerous duodenal adenomas and early stage adenocarcinomas. Sakaguchi Y; Yamamichi N; Tomida S; Takeuchi C; Kageyama-Yahara N; Takahashi Y; Shiogama K; Inada KI; Ichinose M; Fujishiro M; Koike K J Gastroenterol; 2019 Feb; 54(2):131-140. PubMed ID: 29951927 [TBL] [Abstract][Full Text] [Related]
30. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas. Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223 [TBL] [Abstract][Full Text] [Related]
31. Involvement of nuclear NHERF1 in colorectal cancer progression. Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563 [TBL] [Abstract][Full Text] [Related]
32. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers. Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398 [TBL] [Abstract][Full Text] [Related]
33. The Expression and Significance of CXCR5 and MMP-13 in Colorectal Cancer. Yan Q; Yuan Y; Yankui L; Jingjie F; Linfang J; Yong P; Dong H; Xiaowei Q Cell Biochem Biophys; 2015 Sep; 73(1):253-9. PubMed ID: 25726157 [TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon. Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934 [TBL] [Abstract][Full Text] [Related]
35. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Wong SC; Lo ES; Lee KC; Chan JK; Hsiao WL Clin Cancer Res; 2004 Feb; 10(4):1401-8. PubMed ID: 14977843 [TBL] [Abstract][Full Text] [Related]
36. [Expressions and significance of STAT3 and p38 in the carcinogenesis of sporadic colorectal tubular adenoma]. Liu HM; Wu WX; Zhang XH; Lü GH; Zhang JY Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):514-7. PubMed ID: 18069631 [TBL] [Abstract][Full Text] [Related]
37. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma. Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469 [TBL] [Abstract][Full Text] [Related]
38. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Wong SC; Lo ES; Chan AK; Lee KC; Hsiao WL Mol Pathol; 2003 Dec; 56(6):347-52. PubMed ID: 14645698 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389 [TBL] [Abstract][Full Text] [Related]
40. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer. Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]